Cambridge Investment Research Advisors
CDNA icon

Cambridge Investment Research Advisors’s CareDx CDNA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-84,481
Closed -$2.12M – 2289
2018
Q4 		$2.12M Buy
84,481
+4,580
+6% +$118K 0.02% 618
2018
Q3 		$2.31M Sell
79,901
-7,847
-9% -$147K 0.02% 631
2018
Q2 		$1.07M Buy
87,748
+6,418
+8% +$73.6K 0.01% 936
2018
Q1 		$648K Buy
81,330
+16,904
+26% +$104K 0.01% 1192
2017
Q4 		$473K Buy
64,426
+35,851
+125% +$224K 0.01% 1356
2017
Q3 		$106K Buy
+28,575
New +$60K ﹤0.01% 1915

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Cambridge Investment Research Advisors's CDNA Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of CareDx (CDNA) in Q1 2019, closing a stake of 84,481 shares — an estimated $2.12M sold.

Cambridge Investment Research Advisors first reported a position in CDNA in Q3 2017 and held it in 6 quarters. The position peaked at $2.31M in Q3 2018. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.

  • Cambridge Investment Research Advisors reported no remaining CareDx position as of Q1 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 84,481 CareDx shares in Q1 2019, an estimated $2.12M.
  • Cambridge Investment Research Advisors first reported a position in CareDx in Q3 2017 and held it in 6 quarters.
  • Cambridge Investment Research Advisors's CareDx position peaked at $2.31M in Q3 2018.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.